Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Canagliflozin> ?p ?o. }
Showing items 1 to 80 of
80
with 100 items per page.
- Canagliflozin abstract "Canagliflozin (INN, trade name Invokana) is a drug for the treatment of type 2 diabetes. It was developed by Mitsubishi Tanabe Pharma and is marketed under license by Janssen, a division of Johnson & Johnson.In March 2013, canagliflozin became the first SGLT2 inhibitor to be approved in the United States.On July 4, 2011, the European Medicines Agency approved a paediatric investigation plan and granted both a deferral and a waiver for canagliflozin (EMEA-001030-PIP01-10) in accordance with EC Regulation No.1901/2006 of the European Parliament and of the Council.".
- Canagliflozin atcPrefix "A10".
- Canagliflozin atcSuffix "BX11".
- Canagliflozin bioavailability "65.0".
- Canagliflozin casNumber "842133-18-0".
- Canagliflozin chEBI "73274".
- Canagliflozin fdaUniiCode "6S49DGR869".
- Canagliflozin iupacName "(2S,3R,4R,5S,6R)-2-{3-[5-[4-Fluoro-phenyl)-thiophen-2-ylmethyl]-4-methyl-phenyl}-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol".
- Canagliflozin pubchem "24812758".
- Canagliflozin thumbnail Canagliflozin.svg?width=300.
- Canagliflozin wikiPageID "23888680".
- Canagliflozin wikiPageRevisionID "603178202".
- Canagliflozin alt "300".
- Canagliflozin atcPrefix "A10".
- Canagliflozin atcSuffix "BX11".
- Canagliflozin bioavailability "65.0".
- Canagliflozin c "24".
- Canagliflozin casNumber "842133".
- Canagliflozin chebi "73274".
- Canagliflozin chemspiderid "26333259".
- Canagliflozin eliminationHalfLife "42480.0".
- Canagliflozin excretion "Fecal and 33% renal".
- Canagliflozin f "1".
- Canagliflozin h "25".
- Canagliflozin hasPhotoCollection Canagliflozin.
- Canagliflozin inchi "1".
- Canagliflozin inchikey "XTNGUQKDFGDXSJ-ZXGKGEBGBZ".
- Canagliflozin iupacName "-2".
- Canagliflozin legalUs "Rx-only".
- Canagliflozin metabolism Glucuronidation.
- Canagliflozin metabolism Liver.
- Canagliflozin molecularWeight "444.52".
- Canagliflozin o "5".
- Canagliflozin pregnancyUs "C".
- Canagliflozin proteinBound "99.0".
- Canagliflozin pubchem "24812758".
- Canagliflozin routesOfAdministration "Oral".
- Canagliflozin s "1".
- Canagliflozin smiles "Cc1ccc[C@H]4[C@@H]O".
- Canagliflozin stdinchi "1".
- Canagliflozin stdinchikey "XTNGUQKDFGDXSJ-ZXGKGEBGSA-N".
- Canagliflozin synonyms "JNJ-24831754; TA-7284; -1,5-anhydro-1-C-[3-[[5--2-thienyl]methyl]-4-methylphenyl]-(D)-glucitol".
- Canagliflozin tradename "Invokana".
- Canagliflozin unii "6".
- Canagliflozin verifiedfields "changed".
- Canagliflozin verifiedrevid "416773181".
- Canagliflozin watchedfields "changed".
- Canagliflozin subject Category:Glycosides.
- Canagliflozin subject Category:Johnson_&_Johnson.
- Canagliflozin subject Category:Organofluorides.
- Canagliflozin subject Category:SGLT2_inhibitors.
- Canagliflozin subject Category:Thiophenes.
- Canagliflozin type Abstraction100002137.
- Canagliflozin type Chemical114806838.
- Canagliflozin type Compound114818238.
- Canagliflozin type Glycoside114887305.
- Canagliflozin type Glycosides.
- Canagliflozin type Material114580897.
- Canagliflozin type Matter100020827.
- Canagliflozin type OrganicCompound114727670.
- Canagliflozin type Part113809207.
- Canagliflozin type PhysicalEntity100001930.
- Canagliflozin type Relation100031921.
- Canagliflozin type Substance100019613.
- Canagliflozin type Drug.
- Canagliflozin type DrugProduct.
- Canagliflozin type FunctionalSubstance.
- Canagliflozin comment "Canagliflozin (INN, trade name Invokana) is a drug for the treatment of type 2 diabetes.".
- Canagliflozin label "Canagliflozin".
- Canagliflozin label "Canagliflozin".
- Canagliflozin label "Canagliflozine".
- Canagliflozin sameAs Canagliflozine.
- Canagliflozin sameAs Canagliflozin.
- Canagliflozin sameAs m.076y2dt.
- Canagliflozin sameAs Q5030940.
- Canagliflozin sameAs Q5030940.
- Canagliflozin sameAs Canagliflozin.
- Canagliflozin wasDerivedFrom Canagliflozin?oldid=603178202.
- Canagliflozin depiction Canagliflozin.svg.
- Canagliflozin isPrimaryTopicOf Canagliflozin.
